The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porgador, A.
Right arrow Articles by Gilboa, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porgador, A.
Right arrow Articles by Gilboa, E.

The Journal of Immunology, Vol 156, Issue 8 2918-2926, Copyright © 1996 by American Association of Immunologists

ARTICLES

Induction of antitumor immunity using bone marrow-generated dendritic cells

A Porgador, D Snyder and E Gilboa
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

We have previously shown that bone marrow-generated dendritic cells (DC) pulsed with a class I-restricted peptide are potent inducers of CD8+ CTL. In the present study we have investigated whether bone marrow- generated DC are capable of inducing antitumor immunity. We show that a single immunization with DC pulsed with OVA peptide was highly effective in eliciting a protective immune response against a challenge with tumor cells expressing the OVA gene (E.G7-OVA), more so than immunization with irradiated E.G7-OVA cells, OVA peptide-pulsed RMA-S cells, or free OVA peptide mixed with adjuvant. The addition of free OVA protein to day 4 or day 7 bone marrow cultures, but not to day 9 mature DC, was also effective in eliciting CTL and engendering antitumor immunity, but was less effective than peptide-pulsed DC. Induction of CTL and antitumor immunity by bone marrow-generated DC pulsed with the class I-restricted OVA peptide correlated with the expression of syngeneic MHC class II molecules on the DC. This and the fact that induction of tumor immunity was dependent on CD4+ T cells suggest that in vivo priming of CTL and induction of antitumor immunity by bone marrow-generated DC also require the presentation of MHC class II-restricted epitopes and activation of CD4+ T cells. This observation has potentially important implications to the use of peptide-pulsed DC in clinical immunotherapy.


This article has been cited by other articles:


Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. Grolleau-Julius, M. R. Garg, R. Mo, L. L. Stoolman, and R. L. Yung
Effect of Aging on Bone Marrow-Derived Murine CD11c+CD4-CD8{alpha}- Dendritic Cell Function.
J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2006; 61(10): 1039 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Hu, X. Yuan, M. L. Belladonna, J. M. Ong, S. Wachsmann-Hogiu, D. L. Farkas, K. L. Black, and J. S. Yu
Induction of Potent Antitumor Immunity by Intratumoral Injection of Interleukin 23-Transduced Dendritic Cells.
Cancer Res., September 1, 2006; 66(17): 8887 - 8896.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Kim, M. Emi, K. Tanabe, and K. Arihiro
Tumor-Driven Evolution of Immunosuppressive Networks during Malignant Progression
Cancer Res., June 1, 2006; 66(11): 5527 - 5536.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. I. Slukvin, M. A. Vodyanik, J. A. Thomson, M. E. Gumenyuk, and K.-D. Choi
Directed Differentiation of Human Embryonic Stem Cells into Functional Dendritic Cells through the Myeloid Pathway.
J. Immunol., March 1, 2006; 176(5): 2924 - 2932.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Haase, M. Ejrnaes, A. E. Juedes, T. Wolfe, H. Markholst, and M. G. von Herrath
Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo
Blood, December 15, 2005; 106(13): 4225 - 4233.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Nakayama, R. G. Pergolizzi, and R. G. Crystal
Gene Transfer-Mediated Pre-mRNA Segmental Trans-splicing As a Strategy to Deliver Intracellular Toxins for Cancer Therapy
Cancer Res., January 1, 2005; 65(1): 254 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Saha, S. K. Chatterjee, K. A. Foon, F. J. Primus, S. Sreedharan, K. Mohanty, and M. Bhattacharya-Chatterjee
Dendritic Cells Pulsed with an Anti-Idiotype Antibody Mimicking Carcinoembryonic Antigen (CEA) Can Reverse Immunological Tolerance to CEA and Induce Antitumor Immunity in CEA Transgenic Mice
Cancer Res., July 15, 2004; 64(14): 4995 - 5003.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Jalili, M. Makowski, T. Switaj, D. Nowis, G. M. Wilczynski, E. Wilczek, M. Chorazy-Massalska, A. Radzikowska, W. Maslinski, L. Bialy, et al.
Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells
Clin. Cancer Res., July 1, 2004; 10(13): 4498 - 4508.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. S. Higano, N. J. Vogelzang, J. A. Sosman, A. Feng, D. Caron, and E. J Small
Safety and Biological Activity of Repeated Doses of Recombinant Human Flt3 Ligand in Patients with Bone Scan-Negative Hormone-Refractory Prostate Cancer
Clin. Cancer Res., February 15, 2004; 10(4): 1219 - 1225.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Brandt, S. Bulfone-Paus, D. C. Foster, and R. Ruckert
Interleukin-21 inhibits dendritic cell activation and maturation
Blood, December 1, 2003; 102(12): 4090 - 4098.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Tatsumi, J. Huang, W. E. Gooding, A. Gambotto, P. D. Robbins, N. L. Vujanovic, S. M. Alber, S. C. Watkins, H. Okada, and W. J. Storkus
Intratumoral Delivery of Dendritic Cells Engineered to Secrete Both Interleukin (IL)-12 and IL-18 Effectively Treats Local and Distant Disease in Association with Broadly Reactive Tc1-type Immunity
Cancer Res., October 1, 2003; 63(19): 6378 - 6386.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Gilliet, M. Kleinhans, E. Lantelme, D. Schadendorf, G. Burg, and F. O. Nestle
Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen
Blood, July 1, 2003; 102(1): 36 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Saha, S. K. Chatterjee, K. A. Foon, F. J. Primus, and M. Bhattacharya-Chatterjee
Murine Dendritic Cells Pulsed with an Anti-Idiotype Antibody Induce Antigen-specific Protective Antitumor Immunity
Cancer Res., June 1, 2003; 63(11): 2844 - 2854.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Flynn and B. Stockinger
Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation
Blood, June 1, 2003; 101(11): 4472 - 4478.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Eriksson, M. Fredriksson, I. Nordstrom, and J. Holmgren
Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development
Infect. Immun., April 1, 2003; 71(4): 1740 - 1747.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
E. Gatza and C. Y. Okada
Tumor Cell Lysate-Pulsed Dendritic Cells Are More Effective Than TCR Id Protein Vaccines for Active Immunotherapy of T Cell Lymphoma
J. Immunol., November 1, 2002; 169(9): 5227 - 5235.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Tatsumi, A. Gambotto, P. D. Robbins, and W. J. Storkus
Interleukin 18 Gene Transfer Expands the Repertoire of Antitumor Th1-type Immunity Elicited by Dendritic Cell-based Vaccines in Association with Enhanced Therapeutic Efficacy
Cancer Res., October 15, 2002; 62(20): 5853 - 5858.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
M. A. Steller
Cervical Cancer Vaccines: Progress and Prospects
Reproductive Sciences, September 1, 2002; 9(5): 254 - 264.
[Abstract] [PDF]

Home page
 Int ImmunolHome page
E. B. Olasz, J. Linton, and S. I. Katz
Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner
Int. Immunol., May 1, 2002; 14(5): 493 - 502.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Bachleitner-Hofmann, A. Stift, J. Friedl, R. Pfragner, K. Radelbauer, P. Dubsky, G. Schuller, T. Benko, B. Niederle, C. Brostjan, et al.
Stimulation of Autologous Antitumor T-Cell Responses Against Medullary Thyroid Carcinoma Using Tumor Lysate-Pulsed Dendritic Cells
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1098 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. A. Kemp and F. Ronchese
Tumor-Specific Tc1, But Not Tc2, Cells Deliver Protective Antitumor Immunity
J. Immunol., December 1, 2001; 167(11): 6497 - 6502.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Tatsumi, T. Takehara, T. Kanto, T. Miyagi, N. Kuzushita, Y. Sugimoto, M. Jinushi, A. Kasahara, Y. Sasaki, M. Hori, et al.
Administration of Interleukin-12 Enhances the Therapeutic Efficacy of Dendritic Cell-based Tumor Vaccines in Mouse Hepatocellular Carcinoma
Cancer Res., October 1, 2001; 61(20): 7563 - 7567.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
O. O. Oluwole, H. A. Depaz, R. Gopinathan, A. Ali, M. Garrovillo, M.-X. Jin, M. A. Hardy, and S. F. Oluwole
Indirect Allorecognition in Acquired Thymic Tolerance: Induction of Donor-Specific Permanent Acceptance of Rat Islets by Adoptive Transfer of Allopeptide-Pulsed Host Myeloid and Thymic Dendritic Cells
Diabetes, July 1, 2001; 50(7): 1546 - 1552.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. George-Chandy, N. Mielcarek, I. Nordstrom, J. Holmgren, and K. Eriksson
Vaccination with Bordetella pertussis-Pulsed Autologous or Heterologous Dendritic Cells Induces a Mucosal Antibody Response In Vivo and Protects against Infection
Infect. Immun., June 1, 2001; 69(6): 4120 - 4124.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. W. Ju, Q. Tao, G. Lou, M. Bai, L. He, Y. Yang, and X. Cao
Interleukin 18 Transfection Enhances Antitumor Immunity Induced by Dendritic Cell-Tumor Cell Conjugates
Cancer Res., May 1, 2001; 61(9): 3735 - 3740.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
K. Shimizu, E. K. Thomas, M. Giedlin, and J. J. Mulé
Enhancement of Tumor Lysate- and Peptide-pulsed Dendritic Cell-based Vaccines by the Addition of Foreign Helper Protein
Cancer Res., March 1, 2001; 61(6): 2618 - 2624.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
K. A. Candido, K. Shimizu, J. C. McLaughlin, R. Kunkel, J. A. Fuller, B. G. Redman, E. K. Thomas, B. J. Nickoloff, and J. J. Mulé
Local Administration of Dendritic Cells Inhibits Established Breast Tumor Growth: Implications for Apoptosis-inducing Agents
Cancer Res., January 1, 2001; 61(1): 228 - 236.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
L. A. Lambert, G. R. Gibson, M. Maloney, B. Durell, R. J. Noelle, and R. J. Barth Jr.
Intranodal Immunization with Tumor Lysate-pulsed Dendritic Cells Enhances Protective Antitumor Immunity
Cancer Res., January 1, 2001; 61(2): 641 - 646.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
X.-Y. Wang, L. Kazim, E. A. Repasky, and J. R. Subjeck
Characterization of Heat Shock Protein 110 and Glucose-Regulated Protein 170 as Cancer Vaccines and the Effect of Fever-Range Hyperthermia on Vaccine Activity
J. Immunol., January 1, 2001; 166(1): 490 - 497.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Stager, D. F. Smith, and P. M. Kaye
Immunization with a Recombinant Stage-Regulated Surface Protein from Leishmania donovani Induces Protection Against Visceral Leishmaniasis
J. Immunol., December 15, 2000; 165(12): 7064 - 7071.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. L. Warren, S. K. Bhatia, A. M. Acosta, C. E. Dahle, T. L. Ratliff, A. M. Krieg, and G. J. Weiner
APC Stimulated by CpG Oligodeoxynucleotide Enhance Activation of MHC Class I-Restricted T Cells
J. Immunol., December 1, 2000; 165(11): 6244 - 6251.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Brunner, J. Seiderer, A. Schlamp, M. Bidlingmaier, A. Eigler, W. Haimerl, H.-A. Lehr, A. M. Krieg, G. Hartmann, and S. Endres
Enhanced Dendritic Cell Maturation by TNF-{alpha} or Cytidine-Phosphate-Guanosine DNA Drives T Cell Activation In Vitro and Therapeutic Anti-Tumor Immune Responses In Vivo
J. Immunol., December 1, 2000; 165(11): 6278 - 6286.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Lu and E. Celis
Use of Two Predictive Algorithms of the World Wide Web for the Identification of Tumor-reactive T-Cell Epitopes
Cancer Res., September 1, 2000; 60(18): 5223 - 5227.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
A. P. Vicari, S. Ait-Yahia, K. Chemin, A. Mueller, A. Zlotnik, and C. Caux
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms
J. Immunol., August 15, 2000; 165(4): 1992 - 2000.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. W. Hodge, A. N. Rad, D. W. Grosenbach, H. Sabzevari, A. G. Yafal, L. Gritz, and J. Schlom
Enhanced Activation of T Cells by Dendritic Cells Engineered to Hyperexpress a Triad of Costimulatory Molecules
J Natl Cancer Inst, August 2, 2000; 92(15): 1228 - 1239.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Larsson, D. Messmer, S. Somersan, J.-F. Fonteneau, S. M. Donahoe, M. Lee, P. R. Dunbar, V. Cerundolo, I. Julkunen, D. F. Nixon, et al.
Requirement of Mature Dendritic Cells for Efficient Activation of Influenza A-Specific Memory CD8+ T Cells
J. Immunol., August 1, 2000; 165(3): 1182 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Kikuchi, M. A. S. Moore, and R. G. Crystal
Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors
Blood, July 1, 2000; 96(1): 91 - 99.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Timmerman and R. Levy
Linkage of Foreign Carrier Protein to a Self-Tumor Antigen Enhances the Immunogenicity of a Pulsed Dendritic Cell Vaccine
J. Immunol., May 1, 2000; 164(9): 4797 - 4803.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. P. Linette, S. Shankara, S. Longerich, S. Yang, R. Doll, C. Nicolette, F. I. Preffer, B. L. Roberts, and F. G. Haluska
In Vitro Priming with Adenovirus/gp100 Antigen-Transduced Dendritic Cells Reveals the Epitope Specificity of HLA-A*0201-Restricted CD8+ T Cells in Patients with Melanoma
J. Immunol., March 15, 2000; 164(6): 3402 - 3412.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. N. J. Bullock, T. A. Colella, and V. H. Engelhard
The Density of Peptides Displayed by Dendritic Cells Affects Immune Responses to Human Tyrosinase and gp100 in HLA-A2 Transgenic Mice
J. Immunol., March 1, 2000; 164(5): 2354 - 2361.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Schnell, J. W. Young, A. N. Houghton, and M. Sadelain
Retrovirally Transduced Mouse Dendritic Cells Require CD4+ T Cell Help to Elicit Antitumor Immunity: Implications for the Clinical Use of Dendritic Cells
J. Immunol., February 1, 2000; 164(3): 1243 - 1250.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Ferlazzo, A. Wesa, W.-Z. Wei, and A. Galy
Dendritic Cells Generated Either from CD34+ Progenitor Cells or from Monocytes Differ in Their Ability to Activate Antigen-Specific CD8+ T Cells
J. Immunol., October 1, 1999; 163(7): 3597 - 3604.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Subklewe, A. Chahroudi, A. Schmaljohn, M. G. Kurilla, N. Bhardwaj, and R. M. Steinman
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
Blood, August 15, 1999; 94(4): 1372 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Nishioka, M. Hirao, P. D. Robbins, M. T. Lotze, and H. Tahara
Induction of Systemic and Therapeutic Antitumor Immunity Using Intratumoral Injection of Dendritic Cells Genetically Modified to Express Interleukin 12
Cancer Res., August 1, 1999; 59(16): 4035 - 4041.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Borges, R. E. Miller, J. Jones, K. Ariail, J. Whitmore, W. Fanslow, and D. H. Lynch
Synergistic Action of fms-Like Tyrosine Kinase 3 Ligand and CD40 Ligand in the Induction of Dendritic Cells and Generation of Antitumor Immunity In Vivo
J. Immunol., August 1, 1999; 163(3): 1289 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. F. Hermans, D. S. Ritchie, A. Daish, J. Yang, M. R. Kehry, and F. Ronchese
Impaired Ability of MHC Class II-/- Dendritic Cells to Provide Tumor Protection is Rescued by CD40 Ligation
J. Immunol., July 1, 1999; 163(1): 77 - 81.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Curiel-Lewandrowski, K. Mahnke, M. Labeur, B. Roters, W. Schmidt, R. D. Granstein, T. A. Luger, T. Schwarz, and S. Grabbe
Transfection of Immature Murine Bone Marrow-Derived Dendritic Cells with the Granulocyte-Macrophage Colony-Stimulating Factor Gene Potently Enhances Their In Vivo Antigen-Presenting Capacity
J. Immunol., July 1, 1999; 163(1): 174 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. A. Morse, Y. Deng, D. Coleman, S. Hull, E. Kitrell-Fisher, S. Nair, J. Schlom, M.-E. Ryback, and H. K. Lyerly
A Phase I Study of Active Immunotherapy with Carcinoembryonic Antigen Peptide (CAP-1)-pulsed, Autologous Human Cultured Dendritic Cells in Patients with Metastatic Malignancies Expressing Carcinoembryonic Antigen
Clin. Cancer Res., June 1, 1999; 5(6): 1331 - 1338.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Shimizu, R. C. Fields, M. Giedlin, and J. J. Mule
Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines
PNAS, March 2, 1999; 96(5): 2268 - 2273.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Shrikant and M. F. Mescher
Control of Syngeneic Tumor Growth by Activation of CD8+ T Cells: Efficacy Is Limited by Migration Away from the Site and Induction of Nonresponsiveness
J. Immunol., March 1, 1999; 162(5): 2858 - 2866.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. A. Foon, J. Yannelli, and M. Bhattacharya-Chatterjee
Colorectal Cancer as a Model for Immunotherapy
Clin. Cancer Res., February 1, 1999; 5(2): 225 - 236.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Mulders, C.-L. Tso, B. Gitlitz, R. Kaboo, A. Hinkel, S. Frand, S. Kiertscher, M. D. Roth, J. deKernion, R. Figlin, et al.
Presentation of Renal Tumor Antigens by Human Dendritic Cells Activates Tumor-infiltrating Lymphocytes against Autologous Tumor: Implications for Live Kidney Cancer Vaccines
Clin. Cancer Res., February 1, 1999; 5(2): 445 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Morse, R. E. Coleman, G. Akabani, N. Niehaus, D. Coleman, and H. K. Lyerly
Migration of Human Dendritic Cells after Injection in Patients with Metastatic Malignancies
Cancer Res., January 1, 1999; 59(1): 56 - 58.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. De Veerman, C. Heirman, S. Van Meirvenne, S. Devos, J. Corthals, M. Moser, and K. Thielemans
Retrovirally Transduced Bone Marrow-Derived Dendritic Cells Require CD4+ T Cell Help to Elicit Protective and Therapeutic Antitumor Immunity
J. Immunol., January 1, 1999; 162(1): 144 - 151.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. S. Labeur, B. Roters, B. Pers, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe
Generation of Tumor Immunity by Bone Marrow-Derived Dendritic Cells Correlates with Dendritic Cell Maturation Stage
J. Immunol., January 1, 1999; 162(1): 168 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Cao, W. Zhang, L. He, Z. Xie, S. Ma, Q. Tao, Y. Yu, H. Hamada, and J. Wang
Lymphotactin Gene-Modified Bone Marrow Dendritic Cells Act as More Potent Adjuvants for Peptide Delivery to Induce Specific Antitumor Immunity
J. Immunol., December 1, 1998; 161(11): 6238 - 6244.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Brossart, F. Grunebach, G. Stuhler, V. L. Reichardt, R. Mohle, L. Kanz, and W. Brugger
Generation of Functional Human Dendritic Cells From Adherent Peripheral Blood Monocytes by CD40 Ligation in the Absence of Granulocyte-Macrophage Colony-Stimulating Factor
Blood, December 1, 1998; 92(11): 4238 - 4247.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. F. Mackey, J. R. Gunn, C. Maliszewski, H. Kikutani, R. J. Noelle, and R. J. Barth Jr.
Cutting Edge: Dendritic Cells Require Maturation via CD40 to Generate Protective Antitumor Immunity
J. Immunol., September 1, 1998; 161(5): 2094 - 2098.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Guillaume, D. B. Rubinstein, and M. Symann
Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation
Blood, September 1, 1998; 92(5): 1471 - 1490.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Bohm, S. Thoma, F. Leithauser, P. Moller, R. Schirmbeck, and J. Reimann
T Cell-Mediated, IFN-{gamma}-Facilitated Rejection of Murine B16 Melanomas
J. Immunol., July 15, 1998; 161(2): 897 - 908.